The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2
暂无分享,去创建一个
Wei Chen | F. Zhou | Jun‐hang Luo | Jiaxing Zhang | Zhen-hua Chen | Wei Chen | Junhang Luo | Zhiling Zhang | Fangjian Zhou | Jun Lu | Zhenhua Chen | Jiaxing Zhang | Zhiling Zhang | Zihao Feng | Jinhuan Wei | Yong Fang | Yanping Liang | Junjie Cen | Yihui Pan | Yong Huang | Yong Fang | Jun Lu | Zi-hao Feng | Yong Huang | Yanping Liang | J. Cen | Jinhuan Wei | Yihui Pan | Yan-ping Liang | Junjie Cen
[1] J. Foidart,et al. Regulation of vimentin by SIP1 in human epithelial breast tumor cells , 2006, Oncogene.
[2] G. Hannon,et al. Control of translation and mRNA degradation by miRNAs and siRNAs. , 2006, Genes & development.
[3] J. Nesland,et al. Snail, Slug, and Smad‐interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma , 2005, Cancer.
[4] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[5] K. Birkenkamp-Demtroder,et al. MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL. , 2012, Carcinogenesis.
[6] A. Evans,et al. miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215 , 2011, British Journal of Cancer.
[7] V. Bilim,et al. Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3β. , 2012, Cancer letters.
[8] Paul L. Roebuck,et al. TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer. , 2015, Cancer research.
[9] W Marston Linehan,et al. Genetic basis of kidney cancer: Role of genomics for the development of disease-based therapeutics , 2012, Genome research.
[10] Yumei Du,et al. Elevation of Highly Up-regulated in Liver Cancer (HULC) by Hepatitis B Virus X Protein Promotes Hepatoma Cell Proliferation via Down-regulating p18* , 2012, The Journal of Biological Chemistry.
[11] G. Yousef,et al. miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1 , 2015, Oncotarget.
[12] G. Berx,et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. , 2001, Molecular cell.
[13] M. Stern,et al. MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor , 2013, Oncogene.
[14] D. Rimm,et al. X-Tile , 2004, Clinical Cancer Research.
[15] Hui Zhou,et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data , 2013, Nucleic Acids Res..
[16] Hanlin Gao,et al. MicroRNA profiling of clear cell renal cell carcinoma by whole‐genome small RNA deep sequencing of paired frozen and formalin‐fixed, paraffin‐embedded tissue specimens , 2010, The Journal of pathology.
[17] Doron Betel,et al. The microRNA.org resource: targets and expression , 2007, Nucleic Acids Res..
[18] J. Massagué,et al. Epithelial-Mesenchymal Transitions Twist in Development and Metastasis , 2004, Cell.
[19] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[20] G. Bhanot,et al. Identification of a microRNA panel for clear-cell kidney cancer. , 2010, Urology.
[21] J. Thiery. Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.
[22] N. Seki,et al. Epithelial–mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma , 2013, Journal of Human Genetics.
[23] K. Imai,et al. Expression of SIP1 in oral squamous cell carcinomas: implications for E-cadherin expression and tumor progression. , 2005, International journal of oncology.
[24] A. Jemal,et al. Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.
[25] Andrea Califano,et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. , 2010, Cancer cell.
[26] Jun‐hang Luo,et al. Protein Expression of ZEB2 in Renal Cell Carcinoma and Its Prognostic Significance in Patient Survival , 2013, PloS one.
[27] 槻木 真明. Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3β , 2012 .
[28] K. Miyazaki,et al. Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells , 2004, British Journal of Cancer.
[29] Wenfang Li,et al. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway , 2016, Tumor Biology.
[30] Andrea Ventura,et al. MicroRNAs and Cancer: Short RNAs Go a Long Way , 2009, Cell.
[31] R. Plasterk,et al. The diverse functions of microRNAs in animal development and disease. , 2006, Developmental cell.
[32] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[33] Xing-Sui Lu,et al. miR-141 Is a Key Regulator of Renal Cell Carcinoma Proliferation and Metastasis by Controlling EphA2 Expression , 2014, Clinical Cancer Research.
[34] Birgit Luber,et al. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. , 2002, The American journal of pathology.
[35] Chaochun Liu,et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. , 2013, Molecular cell.
[36] Lin He,et al. MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.
[37] R. Dahiya,et al. MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer. , 2011, Cancer research.
[38] Rajvir Dahiya,et al. MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. , 2011, Cancer research.
[39] M. Seto,et al. Genome‐wide microRNA expression profiling in renal cell carcinoma: significant down‐regulation of miR‐141 and miR‐200c , 2008, The Journal of pathology.
[40] Yi-Hsuan Chen,et al. miRNAMap 2.0: genomic maps of microRNAs in metazoan genomes , 2007, Nucleic Acids Res..
[41] Jarek Meller,et al. VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma. , 2012, Cancer cell.
[42] Ke Chen,et al. LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma , 2015, Oncotarget.
[43] H. Dweep,et al. miRWalk2.0: a comprehensive atlas of microRNA-target interactions , 2015, Nature Methods.
[44] D. Cacchiarelli,et al. A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA , 2011, Cell.
[45] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[46] Masaomi Kato,et al. microRNAs: small molecules with big roles –C. elegans to human cancer , 2008, Biology of the cell.
[47] H. Al-Ahmadie,et al. Recent developments in the pathology of renal tumors: morphology and molecular characteristics of select entities. , 2009, Archives of pathology & laboratory medicine.